Bulletins and Briefs

NDIC produces bulletins and briefs to address specific drug-related threats identified through our contacts with local, state, regional, and federal agencies. If you cannot find a previously listed report, please review our Archived Publications list. PDF files are provided to produce high quality copies of our products. These may be viewed with a free copy of Adobe Acrobat Reader.

Listed Alphabetically

Buprenorphine: Potential for Abuse--Intelligence Bulletin
September 2004
Product No. 2004-L0424-013  html   pdf  (370 KB)
This bulletin addresses the use of buprenorphine, a drug recently approved for use in opiate addiction therapy. It examines the drug's effects, advantages of traditional treatment options, and vulnerability to diversion and abuse.

Children at Risk--Information Bulletin
July 2002
Product No. 2002-L0424-001  html   pdf  (415 KB)
En Español 2003-L0508-002  html   pdf  (248 KB)
This information bulletin provides information on the risks to children who are exposed to chemicals used in the production of methamphetamine.

Crystal Methamphetamine--Information Bulletin
August 2002
Product No. 2002-L0424-005  html   pdf  (280 KB)
En Español 2003-L0508-003  html   pdf  (261 KB)
This information bulletin provides an update on the availability of, demand for, production, transportation, and distribution of crystal methamphetamine.

DXM (Dextromethorphan)--Intelligence Bulletin
October 2004
Product No. 2004-L0424-029  html   pdf  (332 KB)
This intelligence bulletin provides an assessment of DXM availability and abuse in the United States.

GHB Analogs: GBL, BD, GHV, and GVL--Information Bulletin
August 2002
Product No. 2002-L0424-003  html   pdf  (391 KB)
This information bulletin provides an update on the availability of, demand for, production, transportation, and distribution of GHB analogs.

GHB Trafficking and Abuse--Intelligence Bulletin
September 2004
Product No. 2004-L0424-015  html   pdf  (294 KB)
This report provides an assessment of GHB (gamma-hydroxybutyrate) trafficking and abuse in the United States. It includes information on the drug's availability, abuse, production, transportation and distribution.

To Top

Huffing - The Abuse of Inhalants--Intelligence Brief
November 2001
Product No. 2002-J0403-001  html   pdf  (327 KB)
En Español 2002-L0508-002  html   pdf  (556 KB)
En Français 2002-L0521-002  html   pdf  (258 KB)
This intelligence brief discusses the abuse of inhalants in the United States.

Iodine in Methamphetamine Production--Information Brief
July 2002
Product No. 2002-L0490-002  html   pdf  (492 KB)
En Español 2003-L0508-004  html   pdf  (237 KB)
This information brief discusses the use of iodine in methamphetamine production, its hazards, availability, theft and diversion, and attempts at control by legislation.

Ketamine--Intelligence Bulletin
July 2004
Product No. 2004-L0424-007  html   pdf  (261 KB)
This Intelligence Bulletin discusses the trafficking and abuse of ketamine hydrochloride. It presents background information, smuggling from Mexico, abuse, effects, and its use in drug-facilitated sexual assault.

Khat (Catha edulis)--Intelligence Bulletin
May 2003
Product No. 2003-L0424-002  html   pdf  (589 KB)
This bulletin indicates that the availability of khat, a plant containing stimulants regulated under the Controlled Substances Act, is increasing in the United States.

LSD Trafficking and Abuse--Intelligence Bulletin
September 2004
Product No. 2004-L0424-026  html   pdf  (261 KB)
This intelligence bulletin provides an assessment of LSD trafficking and abuse in the United States.

Methamphetamine-Related Identity Theft--Intelligence Bulletin
May 2007
Product No. 2007-L0424-003  html   pdf  (534 KB)
This bulletin documents the relationship between the trafficking and distribution of methamphetamine and the crime of identity theft.

PCP: Increasing Availability and Abuse--Intelligence Bulletin
September 2004
Product No. 2004-L0424-002  html   pdf  (331 KB)
This Intelligence Bulletin provides law enforcement, seizure, and treatment data indicating that PCP availability and abuse are increasing in some areas of the country, particularly in metropolitan areas. Though considered a minor threat in comparison to other illicit drugs, the resurgence of PCP poses a significant threat to the United States.

To Top